Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
142.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.281%)
Market Cap: £359.86m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Trading Update

9 Dec 2016 07:00

RNS Number : 3840R
Marshalls PLC
09 December 2016
Β 

Β 

Trading Update: 9 December 2016

Β 

Trading Performance

Β 

Marshalls' revenue for the 11 months ended 30 November 2016 was up 3 per cent at Β£375 million (2015: Β£365 million).

Β 

UK revenue since the half year is up 4 per cent compared with the 2015 comparatives, and was particularly strong in the Domestic end market which, in the 5 months ended 30 November 2016, was up 15 per cent.

Β 

Sales to the Domestic end market for the 11 months ended 30 November 2016, which represent approximately 31 per cent of Group sales, were up 10 per cent compared with the prior year period. The survey of domestic installers at the end of October 2016 revealed order books of 11.0 weeks (October 2015: 11.2 weeks) and compared with 11.7 weeks at the end of June 2016.

Β 

Sales to the Public Sector and Commercial end market now represent approximately 64 per cent of Marshalls' sales. Commercial sales are broadly in line with the prior year. Based on public indicators we believe we continue to outperform our peers and gain market share.

Β 

Good progress has been made in the year to deliver the growth initiatives set out in the 2020 Strategy. The self-help programme to support organic growth is advanced and the drive for sustainable operational improvements is proving successful.

Β 

Dividend

Β 

The 2016 interim dividend of 2.90 pence per share, announced on 26 August 2016, was paid on 2 December 2016 to shareholders registered at the close of business on 20 October 2016.

Β 

We continue to be confident in our ability to meet our capital allocation objectives of investing in the core business, rewarding shareholders and maintaining financial prudence.

Β 

Outlook

Β 

The Board is confident of meeting its 2016 expectations. Alongside this, the underlying indicators have remained positive in Marshalls' main end markets while order intake and revenue growth remains robust and the positive cash generation reported at the Half Year has continued. Management continue to selectively identify and monitor bolt-on acquisitions in line with our 2020 Strategy. These will only be made if they meet our robust appraisal criteria.

Β 

Looking ahead into 2017, the Board notes the modest growth levels highlighted by the recent Construction Products Association autumn forecasts. The Board believes the Group's innovative product range, strong market positions and robust balance sheet mean it is well placed to deliver continued operational and profit improvements.

Β 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

+44(0)1422 314777

Jack Clarke

Finance Director

Β 

Andrew Jaques

MHP Communications

+44(0)20 3128 8540

James White

Β 

Note to the Editor:

Β 

About Marshalls:

Β 

Established in the late 1880s, Marshalls is the UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. Marshalls provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

Β 

Marshalls operates its own quarries and manufacturing sites throughout the UK, including a national network of manufacturing and distribution sites, and has operations in Belgium and sales representation in other international markets. As a major plc, Marshalls is committed to quality in everything it does, including the achievement of high environmental and ethical standards and continual improvement in health and safety performance.

Β 

Forward-Looking Statements:

Β 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2015.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTFMMGZNRFGVZM
Date   Source Headline
10th Dec 202412:28 pmRNSDirector/PDMR Shareholding
10th Dec 202412:26 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSCapital Markets Event
14th Nov 202410:45 amRNSHolding(s) in Company
12th Nov 202412:02 pmRNSDirector/PDMR Shareholding
12th Nov 202411:47 amRNSDirector/PDMR Shareholding
12th Nov 202411:44 amRNSDirector/PDMR Shareholding
31st Oct 202411:18 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSQ3 Trading Update
15th Oct 20249:45 amRNSDirector/PDMR Shareholding
15th Oct 20249:43 amRNSDirector/PDMR Shareholding
15th Oct 20249:42 amRNSDirector/PDMR Shareholding
10th Sep 20244:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20242:57 pmRNSDirector/PDMR Shareholding
16th Aug 202411:21 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSHalf-year Report
25th Jul 20247:00 amRNSNotice of Interim Results
3rd Jun 20243:17 pmRNSDirector/PDMR Shareholding
15th May 20241:01 pmRNSResult of AGM
15th May 20247:00 amRNSTrading Statement
29th Apr 20243:25 pmRNSDirector/PDMR Shareholding - Correction
29th Apr 202411:45 amRNSDirector/PDMR Shareholding
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTrading Statement
17th Oct 202311:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.